NCT06231680 2024-03-29
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Phase 2 Unknown
Clinical Trials
11 trialsNCT05490667 2023-10-30
Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor
Henan Cancer Hospital
Phase NA Unknown
NCT04681287 2023-09-25
Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone.
Henan Cancer Hospital
Phase 2 Unknown
NCT05322486 2022-04-11
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
State Scientific Centre of Coloproctology, Russian Federation
Unknown
NCT03957733 2022-04-06
Phase II/III Study to Assess the Efficacy of Neoadjuvant Consolidation Chemotherapy in Rectal Cancer Patients.
King Abdullah Medical City
Phase 2/3 Unknown
NCT04319471 2020-03-24
Sufficient Chemotherapy Combine With Maintenance Chemotherapy in the Treatment of Oligometastatic Nasopharyngeal Carcinoma
Fujian Cancer Hospital
Phase 2 Unknown
NCT03985670 2019-12-12
Teripalimab Plus Chemotherapy in Local Advanced Esophageal Cancer
Henan Cancer Hospital
Phase 2 Unknown
NCT04134247 2019-10-22
Study of PD-1 Monoclonal Antibody in Combination With Chemotherapy in Patients With RR NHL
Shandong Provincial Hospital
Phase 4 Unknown
NCT03062072 2017-04-07
ECHO
National Cancer Center, Korea
Unknown
NCT02145923 2015-06-10
Effectiveness and Safety of MMSCs for Enhancing Hematopoietic Recovery and Prophylaxis of Neutropenic Enterocolitis
Burnasyan Federal Medical Biophysical Center
Phase 1/2 Unknown
NCT00452803 2010-07-12
Pre-operative Chemotherapy Versus Concurrent Chemoradiotherapy in N2 Positive IIIA Non Small Cell Lung Cancer (NSCLC)
National Cancer Center, Korea
Phase 2 Unknown